2022-502057-33-00CompletedPhase 1/2
A study to investigate safety and efficacy with SAR445514 in participants with relapsed/refractory multiple myeloma (RRMM) and relapsed/refractory light-chain amyloidosis (RRLCA)
Source: EU CTIS (euclinicaltrials.eu) · Last updated 21 May 2025
- Status (registry)
- Completed
- Phase (registry)
- Phase 1/2
- Study type
- Interventional
- Enrollment
- 59 (actual)
- First submitted
- 6 Mar 2023
- Start date
- 2 Oct 2023
- Lead sponsor
- Sanofi-Aventis Recherche & Developpement
- Diseases
- Multiple myeloma, Amyloidosis
- EU CT number
- 2022-502057-33-00
What you commit to
- Study type: Interventional · Phase 1/2
- Participants enrolled: 59
- 13 sites in 6 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (13)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Het Ziekenhuisnetwerk Antwerpen | Antwerp | Belgium | Completed |
| Institut Jules Bordet | Brussels | Belgium | Completed |
| Fakultni nemocnice Brno | Brno | Czechia | Completed |
| Fakultni Nemocnice Ostrava | Poruba | Czechia | Completed |
| Catalan Institute of Oncology | Badalona | Spain | Completed |
| Hospital Clinic de Barcelona | Barcelona | Spain | Completed |
| Hospital Universitario De Salamanca | Salamanca | Spain | Completed |
| Hospital Universitario Marqués de Valdecilla | Santander | Spain | Completed |
| Alexandra Hospital | Athens | Greece | Completed |
| Del-Pesti Centrumkorhaz Orszagos Hematologiai Es Infektologiai Intezet | Budapest IX | Hungary | Completed |
| Semmelweis University | Budapest VIII | Hungary | Completed |
| Humanitas Research Hospital | Rozzano | Italy | Completed |
| Azienda Ospedaliera Universitaria Citta Della Salute E Della Scienza Di Torino | Turin | Italy | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.